Literature DB >> 27371669

Common Mechanisms Underlying Epileptogenesis and the Comorbidities of Epilepsy.

Andrey Mazarati1, Raman Sankar2.   

Abstract

The importance of comorbidities in determining the quality of life of individuals with epilepsy and their families has received increasing attention in the past decade. Along with it has come a recognition that in some individuals, certain comorbidities may have preexisted, and may have contributed to their developing epilepsy. Many mechanisms are capable of interconnecting different dysfunctions that manifest as distinct disorders, often diagnosed and managed by different specialists. We review the human data from the perspective of epidemiology as well as insights gathered from neurodiagnostic and endocrine studies. Animal studies are reviewed to refine our mechanistic understanding of the connections, because they permit the narrowing of variables, which is not possible when studying humans.
Copyright © 2016 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27371669      PMCID: PMC4930916          DOI: 10.1101/cshperspect.a022798

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  157 in total

Review 1.  Rodent models of depression: reexamining validity without anthropomorphic inference.

Authors:  Philip V Holmes
Journal:  Crit Rev Neurobiol       Date:  2003

2.  Depression in temporal lobe epilepsy surgery patients: an FDG-PET study.

Authors:  Michael Salzberg; Taufik Taher; Michael Davie; Ross Carne; Rodney J Hicks; Mark Cook; Michael Murphy; Anita Vinton; Terrence J O'Brien
Journal:  Epilepsia       Date:  2006-12       Impact factor: 5.864

3.  Seizure susceptibility and epileptogenesis in a rat model of epilepsy and depression co-morbidity.

Authors:  S Alisha Epps; Kroshona D Tabb; Sharon J Lin; Alexa B Kahn; Martin A Javors; Katherine A Boss-Williams; Jay M Weiss; David Weinshenker
Journal:  Neuropsychopharmacology       Date:  2012-08-08       Impact factor: 7.853

4.  Regionally selective increases in mu opioid receptor density in the brains of suicide victims.

Authors:  R Gross-Isseroff; K A Dillon; M Israeli; A Biegon
Journal:  Brain Res       Date:  1990-10-22       Impact factor: 3.252

5.  Effect of electrical stimulation of the hippocampus upon corticosteroid levels in the freely-behaving, non-stressed rat.

Authors:  R L Casady; A N Taylor
Journal:  Neuroendocrinology       Date:  1976       Impact factor: 4.914

Review 6.  Mood disorders in patients with epilepsy: epidemiology and management.

Authors:  Cynthia L Harden; Martin A Goldstein
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

7.  Increased cortical GABA concentrations in depressed patients receiving ECT.

Authors:  Gerard Sanacora; Graeme F Mason; Douglas L Rothman; Fahmeed Hyder; James J Ciarcia; Robert B Ostroff; Robert M Berman; John H Krystal
Journal:  Am J Psychiatry       Date:  2003-03       Impact factor: 18.112

8.  Depression and Anxiety in Patients with Epilepsy.

Authors:  Ada Piazzini; Maria Paola Canevini; Giovanna Maggiori; Raffaele Canger
Journal:  Epilepsy Behav       Date:  2001-10       Impact factor: 2.937

9.  Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine.

Authors:  Andréy Mazarati; Prabha Siddarth; Roger A Baldwin; Don Shin; Rochelle Caplan; Raman Sankar
Journal:  Brain       Date:  2008-06-17       Impact factor: 13.501

10.  Different emotional disturbances in two experimental models of temporal lobe epilepsy in rats.

Authors:  Marion Inostroza; Elena Cid; Liset Menendez de la Prida; Carmen Sandi
Journal:  PLoS One       Date:  2012-06-15       Impact factor: 3.240

View more
  11 in total

Review 1.  Recent advances in epilepsy.

Authors:  Mark Manford
Journal:  J Neurol       Date:  2017-01-24       Impact factor: 4.849

2.  Relation of Psychiatric Symptoms with Epilepsy, Asthma, and Allergy in Youth with ASD vs. Psychiatry Referrals.

Authors:  Rebecca J Weber; Kenneth D Gadow
Journal:  J Abnorm Child Psychol       Date:  2017-08

Review 3.  Using Xenopus oocytes in neurological disease drug discovery.

Authors:  Steven L Zeng; Leland C Sudlow; Mikhail Y Berezin
Journal:  Expert Opin Drug Discov       Date:  2019-11-01       Impact factor: 6.098

4.  Expression Analysis of CYFIP1 and CAMKK2 Genes in the Blood of Epileptic and Schizophrenic Patients.

Authors:  Arezou Sayad; Fatemeh Ranjbaran; Soudeh Ghafouri-Fard; Shahram Arsang-Jang; Mohammad Taheri
Journal:  J Mol Neurosci       Date:  2018-07-11       Impact factor: 3.444

5.  Mechanisms of Psychiatric Comorbidities in Epilepsy.

Authors:  Jamie Maguire
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 6.  Serotonergic therapy in epilepsy.

Authors:  Frank G Gilliam; Hrvoje Hecimovic; Matthew S Gentry
Journal:  Curr Opin Neurol       Date:  2021-04-01       Impact factor: 5.710

Review 7.  Depression and Anxiety in the Epilepsies: from Bench to Bedside.

Authors:  Vaishnav Krishnan
Journal:  Curr Neurol Neurosci Rep       Date:  2020-07-14       Impact factor: 6.030

8.  Network Dysfunction in Comorbid Psychiatric Illnesses and Epilepsy.

Authors:  Phillip L W Colmers; Jamie Maguire
Journal:  Epilepsy Curr       Date:  2020-07-06       Impact factor: 7.500

9.  Case Report: Vortioxetine in the Treatment of Depressive Symptoms in Patients With Epilepsy-Case Series.

Authors:  Marcin Siwek; Aleksandra Gorostowicz; Magdalena Bosak; Dominika Dudek
Journal:  Front Pharmacol       Date:  2022-03-31       Impact factor: 5.810

10.  Epilepsy Benchmarks Area I: Understanding the Causes of the Epilepsies and Epilepsy-Related Neurologic, Psychiatric, and Somatic Conditions.

Authors:  Bernard S Chang; Vaishnav Krishnan; Chris G Dulla; Nathalie Jette; Eric D Marsh; Penny A Dacks; Vicky Whittemore; Annapurna Poduri
Journal:  Epilepsy Curr       Date:  2020-01-22       Impact factor: 7.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.